Rate My Professor Angela Morgan

Morgan's research focuses on the genetic architecture of childhood speech disorders, including stuttering, childhood apraxia of speech, and developmental language disorders. Her team utilizes genomic sequencing, genotype-phenotype studies, and neuroimaging to identify novel causative genes and pathways, having discovered over 30 new genes linked to severe speech impairment. She directs the NHMRC Centre of Research Excellence in the Translational Centre for Speech Disorders and previously led the NHMRC CRE in Speech and Language Neurobiology. Notable achievements include establishing Australia's first speech genomics clinic at the Royal Children's Hospital, facilitating early genetic diagnoses and targeted interventions. Key publications include 'Genetic architecture of childhood speech disorder: a review' (Molecular Psychiatry, 2024), 'Stuttering associated with a pathogenic variant in the chaperone protein cyclophilin 40' (Brain, 2023), 'Expanding the phenotype of Kleefstra syndrome: speech, language and cognition in 103 individuals' (Journal of Medical Genetics, 2024), and 'Aetiology of childhood apraxia of speech: A clinical practice update for paediatricians' (Journal of Paediatrics and Child Health, 2018). Awards include the NHMRC Elizabeth Blackburn Investigator Grant (2021, highest-ranked female applicant), Sir William Kilpatrick Churchill Fellowship (2020), and NHMRC Investigator Grant ($2.8 million, 2025) for gene identification in severe speech disorders. Her work advances precision medicine, reducing diagnostic odysseys and informing pharmacological and gene-editing therapies.